LDLR and obesity disorder: Thus, WT mice were treated with Ldlr antisense oligonucleotide to induce LDL receptor (LDLr) deficiency (as we described previously) (29) and fed a HFHC diet ad libitum for 24 weeks to develop obesity and advanced atherosclerotic plaques.